Form 8-K - Current report:
SEC Accession No. 0001140361-23-043517
Filing Date
2023-09-11
Accepted
2023-09-11 16:05:32
Documents
54
Period of Report
2023-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20010505_8k.htm   iXBRL 8-K 27265
2 EXHIBIT 99.1 ef20010505_ex99-1.htm EX-99.1 80615
6 ef20010505_ex99-1slide1.jpg GRAPHIC 133061
7 ef20010505_ex99-1slide2.jpg GRAPHIC 281710
8 ef20010505_ex99-1slide3.jpg GRAPHIC 177258
9 ef20010505_ex99-1slide4.jpg GRAPHIC 185500
10 ef20010505_ex99-1slide5.jpg GRAPHIC 122886
11 ef20010505_ex99-1slide6.jpg GRAPHIC 200873
12 ef20010505_ex99-1slide7.jpg GRAPHIC 197369
13 ef20010505_ex99-1slide8.jpg GRAPHIC 116472
14 ef20010505_ex99-1slide9.jpg GRAPHIC 194128
15 ef20010505_ex99-1slide10.jpg GRAPHIC 202051
16 ef20010505_ex99-1slide11.jpg GRAPHIC 98001
17 ef20010505_ex99-1slide12.jpg GRAPHIC 164376
18 ef20010505_ex99-1slide13.jpg GRAPHIC 152849
19 ef20010505_ex99-1slide14.jpg GRAPHIC 154941
20 ef20010505_ex99-1slide15.jpg GRAPHIC 152188
21 ef20010505_ex99-1slide16.jpg GRAPHIC 182422
22 ef20010505_ex99-1slide17.jpg GRAPHIC 206860
23 ef20010505_ex99-1slide18.jpg GRAPHIC 187216
24 ef20010505_ex99-1slide19.jpg GRAPHIC 99337
25 ef20010505_ex99-1slide20.jpg GRAPHIC 109302
26 ef20010505_ex99-1slide21.jpg GRAPHIC 177816
27 ef20010505_ex99-1slide22.jpg GRAPHIC 153672
28 ef20010505_ex99-1slide23.jpg GRAPHIC 148765
29 ef20010505_ex99-1slide24.jpg GRAPHIC 140784
30 ef20010505_ex99-1slide25.jpg GRAPHIC 150211
31 ef20010505_ex99-1slide26.jpg GRAPHIC 175905
32 ef20010505_ex99-1slide27.jpg GRAPHIC 87358
33 ef20010505_ex99-1slide28.jpg GRAPHIC 87693
34 ef20010505_ex99-1slide29.jpg GRAPHIC 187579
35 ef20010505_ex99-1slide30.jpg GRAPHIC 100268
36 ef20010505_ex99-1slide31.jpg GRAPHIC 143716
37 ef20010505_ex99-1slide32.jpg GRAPHIC 184558
38 ef20010505_ex99-1slide33.jpg GRAPHIC 125859
39 ef20010505_ex99-1slide34.jpg GRAPHIC 145681
40 ef20010505_ex99-1slide35.jpg GRAPHIC 142461
41 ef20010505_ex99-1slide36.jpg GRAPHIC 146576
42 ef20010505_ex99-1slide37.jpg GRAPHIC 152921
43 ef20010505_ex99-1slide38.jpg GRAPHIC 165334
44 ef20010505_ex99-1slide39.jpg GRAPHIC 165556
45 ef20010505_ex99-1slide40.jpg GRAPHIC 117273
46 ef20010505_ex99-1slide41.jpg GRAPHIC 161803
  Complete submission text file 0001140361-23-043517.txt   9053251

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20230911.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20230911_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20230911_pre.xml EX-101.PRE 16048
48 EXTRACTED XBRL INSTANCE DOCUMENT ef20010505_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 231247767
SIC: 2834 Pharmaceutical Preparations